Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
8(33%)
Results Posted
9%(1 trials)
Terminated
1(4%)

Phase Distribution

Ph not_applicable
18
75%
Ph phase_1
1
4%
Ph phase_3
2
8%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
1(4.8%)
Phase 3Large-scale testing
2(9.5%)
N/ANon-phased studies
18(85.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

8

trials recruiting

Total Trials

24

all time

Status Distribution
Active(11)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
Recruiting6
Active, not recruiting2
Enrolling by invitation2
Not yet recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
8
Success Rate
91.7%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (4.8%)
Phase 32 (9.5%)
N/A18 (85.7%)

Trials by Status

not_yet_recruiting14%
recruiting625%
completed1146%
suspended14%
terminated14%
active_not_recruiting28%
enrolling_by_invitation28%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT05487846Not Applicable

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Recruiting
NCT06422455Not Applicable

Access to Genetic Testing in Underserved Patients With Cancer

Recruiting
NCT05225428Not Applicable

Video Education With Result Dependent dIsclosure

Recruiting
NCT02958462Not Applicable

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Recruiting
NCT02993068Not Applicable

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Suspended
NCT07377006Not Applicable

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Not Yet Recruiting
NCT04254133

Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study

Enrolling By Invitation
NCT05360095Not Applicable

Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education

Completed
NCT04494945Not Applicable

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Recruiting
NCT06630104Not Applicable

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Recruiting
NCT05212428Not Applicable

DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study

Active Not Recruiting
NCT06744595Not Applicable

Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer

Enrolling By Invitation
NCT05325151Not Applicable

Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer

Active Not Recruiting
NCT04447703Not Applicable

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Completed
NCT03460483Not Applicable

Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

Completed
NCT03503097

Genetic Testing for Men With Metastatic Prostate Cancer

Terminated
NCT02823652Not Applicable

Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer

Completed
NCT04456140Phase 1

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Completed
NCT00505466

Transition From Research to Disclosure in Human Genetics

Completed
NCT01850654Not Applicable

Ohio Colorectal Cancer Prevention Initiative

Completed

Drug Details

Intervention Type
OTHER
Total Trials
24